Effects of Homocysteine in Myocardial Infarction Patients in a Tertiary Care Hospital of Pakistan
Homocystine; Metabolic Disorder
About this trial
This is an interventional diagnostic trial for Homocystine; Metabolic Disorder focused on measuring Blood Sedimentation, Cardiovascular Diseases, Diabetes Mellitus, Homocysteine, Leukocytes, Cholesterol
Eligibility Criteria
Inclusion Criteria:
- Aged between 18 and 45 years.
- Enough ability to complete the blood sampling procedure.
- Residents lived in the community and can walk to hospital.
Exclusion Criteria:
- Participants outside the age range.
- History of malignancy, infection and other comorbidities
Sites / Locations
- Mubin Kiyani
Arms of the Study
Arm 1
Arm 2
Arm 3
Other
Experimental
Experimental
Control Group
Non-diabetic cardiac
Diabetic cardiac
The blood sample of 5ml was collected from the subjects via a sterile disposable 5ml syringe. The site for the blood collection was antecubital vein of the forearm, which was cleaned an alcoholic swab. The blood sample was shifted to assigned plain bottle container, where it was allowed to clot at room temperature. The serum sample was separated from the blood sample through a centrifugation process at a speed of 5000 revolutions per minute (rpm) for 15 minutes and stored frozen in another bottle container until the time for analysis
The blood sample of 5ml was collected from the subjects via a sterile disposable 5ml syringe. The site for the blood collection was antecubital vein of the forearm, which was cleaned an alcoholic swab. The blood sample was shifted to assigned plain bottle container, where it was allowed to clot at room temperature. The serum sample was separated from the blood sample through a centrifugation process at a speed of 5000 revolutions per minute (rpm) for 15 minutes and stored frozen in another bottle container until the time for analysis
The blood sample of 5ml was collected from the subjects via a sterile disposable 5ml syringe. The site for the blood collection was antecubital vein of the forearm, which was cleaned an alcoholic swab. The blood sample was shifted to assigned plain bottle container, where it was allowed to clot at room temperature. The serum sample was separated from the blood sample through a centrifugation process at a speed of 5000 revolutions per minute (rpm) for 15 minutes and stored frozen in another bottle container until the time for analysis